Marinomed Biotech AG

Major Shareholding Notification • Feb 21, 2019

Publication Date: 21.02.2019 16:39 EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018 Wien, 21.2.2019

Overview

1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Other 3. Person subject to notification obligation Name: Österreichische Beamtenversicherung, VVaG City: 1016 Wien Country: Österreich 4. Name of shareholder(s):

2. 1. Date on which the threshold was crossed or reached: 20.2.2019
3. 1. Total positions

____________
		% of voting
	% of voting			rights through Total of both Total number of
	rights attached financial/other in % (7.A +			voting rights
	to shares (7.A) instruments		7.B)	of issuer
__ _______________ (7.B.1+7.B.2) __ __
Resulting
situation on
the date on	4,57 %	0,00 %	4,57 %	1 430 772
which threshold
was crossed /
_reached __ __ __ __
Position of
previous
notification
(if_applicable) __ __ __ ___

Details

1. Notified details of the resulting situation:

				____________
A:Voting_rights_attached_to_shares______
			_Numberof_voting_rights _______%of_voting_rights____
	Direct	Indirect	Direct	Indirect
ISIN Code				(Sec 130 BörseG (Sec 133 BörseG (Sec 130 BörseG (Sec 133 BörseG
				___ 2018)__ _2018) __2018)_ 2018)___
				ATMARINOMED6_ _65_321 __ ___4,57_% _______
				SUBTOTAL_A__ ____________65_321_____________ _____________4,57%_______

	____________
	B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG
	2018______________
			Number of voting
			rights that may
Type of				be			% of voting
instrument	Expiration Date Exercise Period acquired if the						rights
					instrument is
	___ ___ ___ __exercised_ _____

				B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG
				2018_____________
Type of	Expiration Exercise		Physical /	Number of	% of voting
instrument	Date	Period	Cash	voting rights	rights
				__ _ ___________ Settlement__ ____ ______
				__ _ __ SUBTOTALB.2_ __ _

_____________________________________________________________________________

1. Information in relation to the person subject to the notification obligation: Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer. 9. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights. 10. Sonstige Kommentare: Die Österreichische Beamtenversicherung hielt per 19.2.2019 16.383 Aktien der Marinomed AG. Durch Wandlung der zuvor gehaltenen Nom. 2 Mio. EUR der 4%V Marinomed-Wandelanleihe 2017-21 bezog sie per 20.2.2019 48.938 Aktien und hält nunmehr 65.321 Aktien der Marinomed AG. Wien am 21.2.2019

	end of announcement	euro adhoc
	--------------------------------------------------------------------------------

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52
indexes:
stockmarkets: Wien
language:	English

Aussendung übermittelt durch euro adhoc The European Investor Relations Service